Biodexa Pharmaceuticals (BDRX) announces that at its General Meeting held earlier, both resolutions put to the Company’s shareholders were duly passed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa Pharmaceuticals Secures Nasdaq Listing Compliance
- Biodexa Pharmaceuticals regains Nasdaq compliance
- Biodexa Pharmaceuticals Plans Strategic Share Value Adjustment
- Biodexa Pharmaceuticals Submits SEC Filing with Auditors’ Nod
- Biodexa Pharmaceuticals releases patient updates on PFS, OS from MAGIC-1 study